Skip to main content
Clinical Trials/IRCT20181106041574N1
IRCT20181106041574N1
Recruiting
Phase 3

Comparison of Once- Versus Twice-Daily Administration of long-acting insulin Detemir in children with type 1 diabetes

Tehran University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diabetes mellitus type 1 (according to ISPAD 2014 criteria)
  • Age at diagnosis: 2\-6 years old
  • Lasting at least 1 year since diagnosis
  • Desire to use insulin Detemir

Exclusion Criteria

  • The use of drugs that are effective on controlling diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials